- Home
- IMCR vs AHCO Comparison
IMCR vs AHCO Comparison
Compare IMCR & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- AHCO
- Stock Information
- Founded
- IMCR 2008
- AHCO N/A
- Country
- IMCR United Kingdom
- AHCO United States
- Employees
- IMCR N/A
- AHCO N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- AHCO Medical/Nursing Services
- Sector
- IMCR Health Care
- AHCO Health Care
- Exchange
- IMCR Nasdaq
- AHCO Nasdaq
- Market Cap
- IMCR 1.7B
- AHCO 1.4B
- IPO Year
- IMCR 2021
- AHCO N/A
- Fundamental
- Price
- IMCR $32.03
- AHCO $9.64
- Analyst Decision
- IMCR Buy
- AHCO Strong Buy
- Analyst Count
- IMCR 13
- AHCO 5
- Target Price
- IMCR $68.73
- AHCO $12.80
- AVG Volume (30 Days)
- IMCR 238.6K
- AHCO 1.0M
- Earning Date
- IMCR 11-06-2024
- AHCO 11-05-2024
- Dividend Yield
- IMCR N/A
- AHCO N/A
- EPS Growth
- IMCR N/A
- AHCO N/A
- EPS
- IMCR N/A
- AHCO N/A
- Revenue
- IMCR $296,312,000.00
- AHCO $3,262,564,000.00
- Revenue This Year
- IMCR $28.88
- AHCO $3.34
- Revenue Next Year
- IMCR $12.61
- AHCO $3.48
- P/E Ratio
- IMCR N/A
- AHCO N/A
- Revenue Growth
- IMCR 25.09
- AHCO 4.49
- 52 Week Low
- IMCR $29.72
- AHCO $6.43
- 52 Week High
- IMCR $76.98
- AHCO $11.90
- Technical
- Relative Strength Index (RSI)
- IMCR 56.41
- AHCO 41.31
- Support Level
- IMCR $32.65
- AHCO $8.60
- Resistance Level
- IMCR $34.78
- AHCO $11.36
- Average True Range (ATR)
- IMCR 1.54
- AHCO 0.57
- MACD
- IMCR 0.21
- AHCO -0.03
- Stochastic Oscillator
- IMCR 74.74
- AHCO 37.68
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.